Skip to menu Skip to content Skip to footer

2010

Conference Publication

COMMON PATHOGENETIC MECHANISMS OF COPD AND LUNG CANCER

Yang, I (2010). COMMON PATHOGENETIC MECHANISMS OF COPD AND LUNG CANCER. 15th Congress of the Asian Pacific Society of Respirology, Manila, Philippines, 22-25 November 2010.

COMMON PATHOGENETIC MECHANISMS OF COPD AND LUNG CANCER

2010

Conference Publication

Characterization of cell lines from human malignant mesothelioma

Relan, V., Quinn, K. R., Tan, M. E., Wright, C. W., Clarke, B. E., Duhig, E. E., Yang, I. A., Fong, K. M. and Bowman, R. V. (2010). Characterization of cell lines from human malignant mesothelioma. The Thoracic Society of Australia & New Zealand (TSANZ) Annual Scientific Meeting 2010, Brisbane, Australia, 19-24 March 2010. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2010.01736.x

Characterization of cell lines from human malignant mesothelioma

2010

Conference Publication

Learning in the Clinical Setting (LICS): A pilot study at the Northside Clinical School and Rural Clinical School

Yang, Ian A., Swadling, Barbara, Bradbear, Robyn, Hatfield, Laurel, Stride, Peter J.O., Livett, Mark, Wright, Morgan, Baker, Peter G., Lake, Fiona, Caputo, Lisa, Peterson, Ray, McAllister, Lindy and Eley, Diann (2010). Learning in the Clinical Setting (LICS): A pilot study at the Northside Clinical School and Rural Clinical School. Medical Education Teaching and Learning Conference, Herston, Brisbane, Australia, 5 November 2010.

Learning in the Clinical Setting (LICS): A pilot study at the Northside Clinical School and Rural Clinical School

2010

Conference Publication

Banking of tissues and body fluids for translational lung research

Martins, M. U., Quinn, K. R., Savarimuthu Francis, S. M., Wright, C. M., Tan, M. E., Passmore, L. H., McCaul, E., Relan, V., Sriram, K. B., Davidson, M. R., De Laat, J. A., Parris, B. A., Campbell, J., Shaw, E. F., Tjahjadi, J., Hunter, S. C., Larsen, J. E., Clarke, B. E., Duhig, E. E., Zimmerman, P. V., Yang, I. A., Bowman, R. V. and Fong, K. M. (2010). Banking of tissues and body fluids for translational lung research. The Thoracic Society of Australia & New Zealand (TSANZ) Annual Scientific Meeting 2010, Brisbane, Qld, Australia, 19-24 March, 2010. Carlton, VIC, Australia: Blackwell Science. doi: 10.1111/j.1440-1843.2010.01736.x

Banking of tissues and body fluids for translational lung research

2010

Conference Publication

Practical Implementation of COPD Guidelines in the Asia-Pacific region: Consensus formation

Yang, Ian (2010). Practical Implementation of COPD Guidelines in the Asia-Pacific region: Consensus formation. Post Graduate Course 15th Congress of the APSR, Manila, Philippines, 22-25 November 2010.

Practical Implementation of COPD Guidelines in the Asia-Pacific region: Consensus formation

2006

Conference Publication

Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors

Molenaar, P., Chen, Lu, Meyers, E., Javorsky, G., Burstow, M., Lucas, P., Lolekha, J., Atherton, A., Semmler, A. B., Savarimuthu, S., Fong, K. M., Yang, I. A., Galbraith, A. and Parsonage, W. A. (2006). Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors. The Australian Health and Medical Research Congress, Melbourn, Australia, 26th November - 1st December, 2006. Australia: Australian Govenment NHMRC.

Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors

2006

Conference Publication

Beta1-adrenoceptor (AR) Arg389Gly polymorphisms affect responses to carvedilol in patients with idiopathic dilated cardiomyopathy

Chen, L., Meyers, D., Semmler, A.B., Yang, I., Pakorn, L., Lucas, M., Jovarsky, G., Savarimuthu, S., Galbraith, A., Parsonage, W. and Molenaar, P. (2006). Beta1-adrenoceptor (AR) Arg389Gly polymorphisms affect responses to carvedilol in patients with idiopathic dilated cardiomyopathy. 15th World Congress of Pharmacology, Beijing, China, 2nd - 7th July, 2006. China: Chinese Pharmacological Society.

Beta1-adrenoceptor (AR) Arg389Gly polymorphisms affect responses to carvedilol in patients with idiopathic dilated cardiomyopathy

2005

Conference Publication

Antibiotics for acute exacerbations of COPD: A systematic review

Yang, I. A., Kim, S. T. and Bell, S. C. (2005). Antibiotics for acute exacerbations of COPD: A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Antibiotics for acute exacerbations of COPD: A systematic review

2005

Conference Publication

Antibiotics in cystic fibrosis (CF): A systematic review

Kim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. Array, Crete, Greece, 22-25 Jun, 2005. Amsterdam, Netherlands: Elsevier BV.

Antibiotics in cystic fibrosis (CF): A systematic review

2005

Conference Publication

Antibiotics in cystic fibrosis (CF): A systematic review

Kim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Antibiotics in cystic fibrosis (CF): A systematic review

2005

Conference Publication

Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype

Kim, S. T., Passmore, L., Dent, A. G., Slaughter, R., Yang, I. A., Fong, K. M., Zimmerman, P. V. and Bell, S. C. (2005). Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype

2002

Conference Publication

The positive inotropic effects of norepinephrine are potentiated by chronic beta1-blocker administration but are conserved across Ser49Gly- and Gly389Arg-beta1-adrenergic receptor polymorphisms in human right atrium

Molenaar, P., Russell, F. D., Rabnott, G., Yang, I., Fong, K. M., Savarimuthu, S. M., Li, L. and West, M. J. (2002). The positive inotropic effects of norepinephrine are potentiated by chronic beta1-blocker administration but are conserved across Ser49Gly- and Gly389Arg-beta1-adrenergic receptor polymorphisms in human right atrium. American Heart Association Scientific Sessions 2002, Chicago, 17-20 Nov, 2002. Hagerstown, U.S.A.: Lippincott Williams & Wilkins.

The positive inotropic effects of norepinephrine are potentiated by chronic beta1-blocker administration but are conserved across Ser49Gly- and Gly389Arg-beta1-adrenergic receptor polymorphisms in human right atrium

2000

Conference Publication

Azithromycin (AZM) reduces TNF- release from lipopolysachcharide (LPS) - stimulated mononuclear cells (PBMC) in cystic fibrosis

Bell, S., Wolter, J. M., Seeney, S. L., Gan, R., Yang, I., Bowler, S. D. and Mccormack, J. G. (2000). Azithromycin (AZM) reduces TNF- release from lipopolysachcharide (LPS) - stimulated mononuclear cells (PBMC) in cystic fibrosis. Fourteenth Annual North American Cystic Fibrosis Conference, Baltimore Maryland, USA, 9-12 Novembe, 2000. New York, USA: Wiley Liss, Div John Wiley & Sons.

Azithromycin (AZM) reduces TNF- release from lipopolysachcharide (LPS) - stimulated mononuclear cells (PBMC) in cystic fibrosis

2000

Conference Publication

Azithromycin (AZM) reduced TNF- release from lipopolysachharide (LPS)-stimulated mononuclear cells (PBMC) in cystic fibrosis (CF)

Wolter, J. M., Seeney, S. L., Yang, I. A., Bowler, S. D., Bell, S. and Mccormack, J. G. (2000). Azithromycin (AZM) reduced TNF- release from lipopolysachharide (LPS)-stimulated mononuclear cells (PBMC) in cystic fibrosis (CF). ASID Annual Scientific Meeting, Laura, NSW, 15-19 April, 2001. Balgowlah NSW: ADIS Press Australia.

Azithromycin (AZM) reduced TNF- release from lipopolysachharide (LPS)-stimulated mononuclear cells (PBMC) in cystic fibrosis (CF)

2000

Conference Publication

Tumour necrosis factor (TNF ), myeloperoxides (MPO) and interleukin-1 receptor antagonist polymorphisms in cystic fibrosis.

Gan, R., Bowler, S. D., Seeney, S. L., Wolter, J.M., Masel, P. J., Bunting, J., Tunnicliffe, A. M., Rabnott, G. C., Yang, I. A. and Bell, S. (2000). Tumour necrosis factor (TNF ), myeloperoxides (MPO) and interleukin-1 receptor antagonist polymorphisms in cystic fibrosis.. Fourteenth Annual North American Cystic Fibrosis Conference, Baltimore Maryland, USA, 9-12 Novewmber, 2000. New York USA: Wiley-Liss.

Tumour necrosis factor (TNF ), myeloperoxides (MPO) and interleukin-1 receptor antagonist polymorphisms in cystic fibrosis.

1999

Conference Publication

b2 adrenergic receptor genotypes in severe asthma

Douglas, J. A., Yang, I., Rabnott, G. C., Tunnicliffe, A. M., McCarthy, J. B., Zimmerman, P. V. and Fong, K. M. (1999). b2 adrenergic receptor genotypes in severe asthma. Heart and Lungs, Canberra, 26 Feb - 3 March 1999. Carlton, Vic.: Blackwell Science.

b2 adrenergic receptor genotypes in severe asthma

1999

Conference Publication

b2 adrenoceptor genotypes and life-threatening asthma

Rabnott, G. C., Tunnicliffe, A. M., Yang, I. A., Douglas, J. A., Shaw, J., McCarthy, J. B., Zimmerman, P. V. and Fong, K. M. (1999). b2 adrenoceptor genotypes and life-threatening asthma. Pulmonary-Renal Interface, Hyatt Regency Sanctuary Cove, 26 - 28 Nov, 1999. Qld.: Thoracic Society of Qld..

b2 adrenoceptor genotypes and life-threatening asthma

1999

Conference Publication

GSTT1 and GSTM1 polymorphisms in Australian chronic obstructive pulmonary disease (COPD) patients

Yang, I. A., Gan, R., Tunniclife, A. M., Rabnott, G. C., Zimmerman, P.V. and Fong, K. M. (1999). GSTT1 and GSTM1 polymorphisms in Australian chronic obstructive pulmonary disease (COPD) patients. European Society Annual Congress, Madrid, Spain, 9 - 13 Oct, 1999. Copenhagen, Denmark: European Respiratory Society & Munksgaard Int. Publishers.

GSTT1 and GSTM1 polymorphisms in Australian chronic obstructive pulmonary disease (COPD) patients

1999

Conference Publication

GSTM1 genotypes in Australian patients with NSCLC

Gan, R., Yang, I., Tunnicliffe, A. M., Rabnott, G. C., Bowman, R., Zimmerman, P.V. and Fong, K. M. (1999). GSTM1 genotypes in Australian patients with NSCLC. Heart and Lungs, Canberra, 26 Feb - 3 March 1999. Carlton, Vic.: Blackwell Science.

GSTM1 genotypes in Australian patients with NSCLC

1999

Conference Publication

GSTM1 and GSTP1 polymorphisms in chronic obstructive pulmonary disease (COPD)

Yang, I. A., Gan, R., Tunnicliffe, A. M., Rabnott, G. C., Slaughter, R., Zimmerman, P.V. and Fong, K. M. (1999). GSTM1 and GSTP1 polymorphisms in chronic obstructive pulmonary disease (COPD). Pulmonary-Renal Interface, Hyatt Regency Sanctuary Cove, 26 - 28 Nov, 1999. Qld.: Thoracic Society of Qld..

GSTM1 and GSTP1 polymorphisms in chronic obstructive pulmonary disease (COPD)